ARO-ATXN2

ARO-ATXN2 · Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-ATXN2, covering 2026-02-06 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2 [Phase 1]